Factors associated with adolescent HPV vaccine use in UTSW and Parkland affiliated clinics

Study ID
STU 092010-230

Cancer Related

Healthy Volunteers

Study Sites

  • Children’s Medical Center (Dallas, Plano, Southlake)
  • Parkland Health & Hospital System
  • UT Southwestern-Other

Emily Marks

Principal Investigator
Jasmin Tiro, Ph.D.


This non-experimental pilot study is designed to identify patient, provider, and clinic characteristics associated with HPV vaccine uptake in a sample of racially and ethnically diverse adolescent females attending 4 primary care clinics in Dallas County. There are two pools of research subjects.

To achieve Specific aims 1 and 2, the research subjects are female patients between the ages of 11 and 18 years old. We expect to randomly select the medical records of 175 adolescent female patients at each clinic site (700 total) in this protocol over a 1 year period. We will be conducting a review of selected patients' medical records and patients will not be contacted. We are requesting for waiver of HiPaa privacy authorization for research.

To achieve Specific aim 3, the research subjects are primary care providers (PCPs) and staff at the 4 primary care clinics in Dallas County. PCPs will be invited to participate in a 1-1.5 hour focus group (8-10 participants in each group, 2 groups per clinic site; 80 total). Clinic and nurse managers will be invited to participate in a 30-45 minute interview (up to 4 participants per site; 16 total). at the beginning of the focus group or interview, PCPs and staff will be asked to complete a short survey regarding their attitudes and experiences with HPV vaccine administration.

Participant Eligibility

Main Study: Female patients between the ages of 11 and 18 years old with an index visit during the study timeframe (3/1/07-2/28/08).
Female patients of all ethnicities and races will be included.

Sub-Study of primary care providers and clinic staff:
Male and female attending physicians, medical residents, and clinic staff